Pipeline

AGING
CARDIOVASCULAR DISEASES
RARE DISEASES
MECHANISM
TARGET ID
& VALIDATION
LEAD OPTIMIZATION
IND-ENABING
STUDIES
PHASE I/II
"Systemic" Senolytics
Undisclosed "True Aging"
Undisclosed
Undisclosed
ONCOLOGY
Undisclosed